Literature DB >> 24623277

Smooth muscle cell-specific Hif-1α deficiency suppresses angiotensin II-induced vascular remodelling in mice.

Masaki Imanishi1, Shuhei Tomita2, Keisuke Ishizawa3, Yoshitaka Kihira1, Masaki Ueno4, Yuki Izawa-Ishizawa1, Yasumasa Ikeda1, Noriko Yamano1, Koichiro Tsuchiya3, Toshiaki Tamaki1.   

Abstract

AIM: Vascular remodelling is mediated by vascular smooth muscle cell (VSMC) proliferation and hypertrophy, both processes of which are linked to medial thickening and fibrosis. Here, we show that hypoxia-inducible factor-1α (Hif-1α) expressed in smooth muscle cells (SMCs) is involved in angiotensin II (Ang II)-induced vascular remodelling in an in vivo model. METHODS AND
RESULTS: To clarify the role of Hif-1α in vascular remodelling, we created mice lacking the Hif-1α gene in SMCs (SMKO mice). Ang II infusion induced medial thickening and vascular fibrosis, accompanied by Hif-1α up-regulation, in the aortae of control mice, but not in those of SMKO mice. In accordance with those results, our in vitro studies showed that the deletion of SMC-derived Hif-1α suppressed the Ang II-induced hypertrophy of VSMCs, and our in vivo studies showed that the Ang II-induced expression of fibrosis-related genes in aortae was suppressed by SMC-specific Hif-1α deficiency. In addition, the SMC-specific Hif-1α deficiency suppressed Ang II-induced macrophage infiltration and Ang II-induced expression of inflammation-related genes in aortae. The superoxide production observed in the aortae of control mice with Ang II was suppressed in those of SMKO mice with Ang II, and this finding was consistent with the results of little Ang II-induced c-Src phosphorylation in SMKO mouse aortae. Loss- and gain-of-function analysis in in vitro experiments confirmed that VSMC-derived Hif-1α functions as an intrinsic modulator of vascular remodelling-related gene expression.
CONCLUSION: Our results revealed that SMC-derived Hif-1α is a crucial mediator of Ang II-induced vascular remodelling. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Angiotensin II; Hypoxia-inducible factor-1 (HIF-1); Vascular remodelling; Vascular smooth muscle

Mesh:

Substances:

Year:  2014        PMID: 24623277     DOI: 10.1093/cvr/cvu061

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  24 in total

1.  Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology.

Authors:  Norah Alruwaili; Sharath Kandhi; Dong Sun; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2018-12-21       Impact factor: 8.401

2.  Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.

Authors:  Takehiko Takayanagi; Steven J Forrester; Tatsuo Kawai; Takashi Obama; Toshiyuki Tsuji; Katherine J Elliott; Elisa Nuti; Armando Rossello; Hang Fai Kwok; Rosario Scalia; Victor Rizzo; Satoru Eguchi
Journal:  Hypertension       Date:  2016-08-01       Impact factor: 10.190

3.  Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.

Authors:  Steven J Forrester; Katherine J Elliott; Tatsuo Kawai; Takashi Obama; Michael J Boyer; Kyle J Preston; Zhen Yan; Satoru Eguchi; Victor Rizzo
Journal:  Hypertension       Date:  2016-11-28       Impact factor: 10.190

Review 4.  AT1 receptor signaling pathways in the cardiovascular system.

Authors:  Tatsuo Kawai; Steven J Forrester; Shannon O'Brien; Ariele Baggett; Victor Rizzo; Satoru Eguchi
Journal:  Pharmacol Res       Date:  2017-05-17       Impact factor: 7.658

Review 5.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Aortic Aneurysm: In Defense of the Vascular Smooth Muscle Cell.

Authors:  Ha Won Kim; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-11       Impact factor: 8.311

Review 7.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

8.  Vascular induction of a disintegrin and metalloprotease 17 by angiotensin II through hypoxia inducible factor 1α.

Authors:  Takashi Obama; Takehiko Takayanagi; Tomonori Kobayashi; Allison M Bourne; Katherine J Elliott; Martine Charbonneau; Claire M Dubois; Satoru Eguchi
Journal:  Am J Hypertens       Date:  2014-05-28       Impact factor: 2.689

Review 9.  Elucidating the Association Between the Upregulation of Angiotensin Type 1-Receptors and the Development of Gastrointestinal Malignancies.

Authors:  Mohammad-Hassan Arjmand
Journal:  J Gastrointest Cancer       Date:  2020-11-10

10.  Augmented vascular smooth muscle cell stiffness and adhesion when hypertension is superimposed on aging.

Authors:  Nancy L Sehgel; Zhe Sun; Zhongkui Hong; William C Hunter; Michael A Hill; Dorothy E Vatner; Stephen F Vatner; Gerald A Meininger
Journal:  Hypertension       Date:  2014-12-01       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.